Skip to content

A retrospective study on the safety and efficacy of microsurgical varicocelectomy & revascularization in the treatment of varicocele

A retrospective study on the safety and efficacy of microsurgical varicocelectomy & revascularization in the treatment of varicocele

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068739
Enrollment
Unknown
Registered
2023-02-28
Start date
2023-02-24
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

varicocele

Interventions

Observation group:none

Sponsors

Xiangya Hospital Central South University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Varicocele diagnosed by ultrasound. Surgical indications for varicocele in accordance with CUA2019 guidelines. Karnofsky score (Annex 1) = 70. From April 2020 to April 2022, he was admitted to Xiangya Hospital of Central South University. Underwent microvaricocele shunt in Xiangya Hospital of Central South University. Laboratory indicators: neutrophil count (ANC) = 1000/mm3, platelet count = 100000/mm3, hemoglobin = 9.0g/dl, bilirubin = 1.5 times of normal limit (normal range specified by the organization), glutamic oxaloacetic transaminase (AST), glutamic pyruvic transaminase (ALT) and alkaline phosphatase = 2.5 times of normal limit, creatinine (Scr) = 1.5mg/dL. CCR = 60ml / min (GC or GC+ICI) or CCR = 30ml / min (ICI) (using Cockcroft-Gault formula: creatinine clearance rate for men = (140-age) * body weight (kg) / 72 * serum creatinine (mg/dl) or creatinine clearance rate = (140-age) * body weight (kq) / [0.818 * serum creatinine (umol/L)])

Exclusion criteria

Exclusion criteria: Lack of clinical and follow-up data. Severe heart disease (i.e. class III and above cardiac function). Severe medical or mental illness, including severe active infections. He has received other surgical treatment within 4 weeks. The following symptoms occur within 6 months: myocardial infarction, severe / unstable angina pectoris, coronary artery / peripheral artery bypass, symptomatic congestive heart failure, cerebrovascular accident or transient ischemic attack. Persistent arrhythmia = 2 grade (NCI CTCAE Version 4.0grade). Diseases or infections related to human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS). He participated in other clinical trials at the same time.

Design outcomes

Primary

MeasureTime frame
Pain relief;Improvement of semen parameters;Operative complication;

Secondary

MeasureTime frame
Relapse rate;satisfaction with the cosmetic outcome;Operation time;hospitalization time after surgery;time to return to normal activities;postoperative pain;

Countries

China

Contacts

Public ContactXiongbing Zu

Xiangya Hospital Central South University

zuxbxyyy@126.com13787157190

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026